Carla Monserrat Ramírez-Martínez

Dr. Carla Monserrat Ramírez-Martínez


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
CRCarla Monserrat Ramírez-Martínez
Carla Monserrat Ramírez-Martínez
LJLuis Fernando Jacinto-Alemán
Luis Fernando Jacinto-Alemán
LHLuis Pablo Cruz Hervert
Luis Pablo Cruz Hervert
JRJAVIER ROBERTSON
JAVIER ROBERTSON
ELElba Rosa Leyva-Huerta
Elba Rosa Leyva-Huerta
Salivary gland neoplasms are a heterogeneous neoplasm group, including mucoepidermoid carcinoma (MECa), adenoid cystic carcinoma (AdCC), and many others. Objective: We aimed to identify new critical genes of MECa and AdCC using bioinformatics analysis. Methods: Gene expression profile of GSE153283 was analyzed by the GEO2R online tool to use the DAVID software for their subsequent enrichment. Protein–protein interactions (PPI) were visualized using String. Cytoscape with MCODE plugin followed by Kaplan–Meier online for overall survival analysis were performed. Results: 97 upregulated genes were identified for MECa and 86 for AdCC. PPI analysis revealed 22 genes for MECa and 63 for AdCC that were validated by Kaplan–Meier that showed FN1 and SPP1 for MECa, and EGF and ERBB2 for AdCC as more significant candidate genes for each neoplasm. Conclusion: With bioinformatics methods, we identify upregulated genes in MECa and AdCC. The resulting candidate genes as possible therapeutic targets were FN1, SPP1, EGF, and ERBB2, and all those genes had been tested as a target in other neoplasm kinds but not salivary gland neoplasm. The bioinformatic evidence is a solid strategy to select them for more extensive research with clinical impact.

14 October 2024 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
LELILIBETH STEPHANIA ESCOTO
LILIBETH STEPHANIA ESCOTO
JRJAVIER ROBERTSON
JAVIER ROBERTSON
JRJosue-Orlando Ramirez-Jarquin
Josue-Orlando Ramirez-Jarquin
LJLuis Fernando Jacinto-Alemán
Luis Fernando Jacinto-Alemán
AAAlejandro Alonso-Moctezuma
Alejandro Alonso-Moctezuma
FSFabiola Salgado-Chavarria
Fabiola Salgado-Chavarria
Oral cancer holds the sixth position in malignancies worldwide; 90% correspond to oral squamous cell carcinoma (OSCC). Diverse reports suggest that NTRK genes and their receptors are key oncogenesis regulators to tumor progression in human cancers. Objective: To analyze the NTRK and Trk expression and their association with clinicopathological features of OSCC in Mexican patients’ samples. Material and Methods: We analyzed 95 OSCC cases of pan-trk immunoexpression through a software-assisted method. Gene expression was analyzed by RT-qPCR employing the ΔΔCT method. Kruskal–Wallis and Spearman’s correlation tests were performed. Results: Our mean age was 62.4 (±16.9) years. A total of 37 cases were tumors in the lateral border of the tongue. Age was significantly associated with the anatomical site. 42% (40 of 95) cases were pan-trk positive. A total of 21 cases showed intense immunoexpression predominantly in poorly differentiated OSCC, with a significant correlation between immunoexpression and age and gender. Gene expression showed that poorly differentiated cases exhibited higher NTRK2 expression, while well-differentiated cases demonstrated NTRK3 significantly higher expression. Conclusions: Our results suggest that NTRK family expression is present in OSCC, with differential expression related to differentiation degree. Additional information about their activation or mutational status could reinforce their potential as a possible primary or adjuvant treatment target.

30 June 2024 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
LVLeslie Villa-Martínez
Leslie Villa-Martínez
BMBlanca Itzel Mendoza-Espinosa
Blanca Itzel Mendoza-Espinosa
LJLuis Fernando Jacinto-Alemán
Luis Fernando Jacinto-Alemán
AAdriana Molotla
Adriana Molotla
CMClaudia Patricia Mejía-Velázquez
Claudia Patricia Mejía-Velázquez
ETElsa Mónica Toriz-Pichardo
Elsa Mónica Toriz-Pichardo
Gingiva hyperpigmentation resulting from physiological melanosis causes aesthetic discomfort and is usually perceived as a disease by patients because healthy attached gingiva is typically characterized by coral pink coloring with stippling and scalloped contours. When physiological melanosis compromises the aesthetics of smiling, it may induce insecurity in patients, who usually seek out alternatives for reducing or eliminating hyperpigmentation. We present a case report of a surgical procedure combining gingivectomy with gingivoplasty for the management of physiological melanosis. The surgical procedure was performed on a 40-year-old female patient with bilateral pigmentation in both arches. The results of the histological analysis confirm the diagnoses of melanotic macula, with papillary hyperplasia and cytopathic changes being suggestive of HPV infection, which was verified using an immunohistochemistry analysis based on the detection of a major capsid protein of HPV. Acceptable functional and aesthetic results were obtained for the patient without major discomfort during the postoperative period. In cases when HPV infection is present, long-term follow-up becomes necessary.

1 January 2024 in Case Reports in Dentistry
Verified
Journal Article
Open access
CQCinthya María Quisiguiña-Salem
Cinthya María Quisiguiña-Salem
AAAlejandro Alonso-Moctezuma
Alejandro Alonso-Moctezuma
CRCarla Monserrat Ramírez-Martínez
Carla Monserrat Ramírez-Martínez
FSFabiola Salgado-Chavarría
Fabiola Salgado-Chavarría
ILItzel Legorreta-Villegas
Itzel Legorreta-Villegas
JJJames Jerez-Robalino
James Jerez-Robalino
Background: The most common odontogenic tumor is the solid ameloblastoma. This is concerning due to the progressive bone destruction in its intraosseous variant; this type of pathology often gets a delayed diagnosis due to the asymptomatic characteristic it has. Objective: The aim of the article is to propose a conservative treatment for multicystic ameloblastoma, reviewing the latest concepts, controversies, and treatment options described in the literature. Case Report: A patient arrives to our department with a diagnosis of unicystic ameloblastoma, so decompression and subsequent enucleation were decided as treatment. However, the new histopathological result was a multicystic ameloblastoma; with this result, we decided to continue with the initial treatment, which in fact had an adequate response. A 5‐month radiographic follow‐up was performed in which a decrease in size was evident and enucleation was decided. The postoperative results were favorable after a 2.5‐year follow‐up. Conclusion: The solid ameloblastoma may have a cystic component, in which there is the possibility of diagnostic errors when studying an incisional biopsy; for this reason, the definitive diagnosis should be established until complete enucleation of the lesion is performed. This characteristic in a solid ameloblastoma makes possible a positive response to decompression, making it easier to perform the enucleation subsequently, avoiding other aggressive treatments that can dramatically affect the patient’s quality of life and also avoiding costly reconstruction bills.

21 November 2022 in Odovtos - International Journal of Dental Sciences
Verified
Journal Article
Open access
PDF file
LMLuis A. Martínez-Marcial
Luis A. Martínez-Marcial
LJLuis F. Jacinto-Alemán
Luis F. Jacinto-Alemán
DTDavid A. Trejo-Remigio
David A. Trejo-Remigio
CRCarla Monserrat Ramírez-Martínez
Carla Monserrat Ramírez-Martínez
ELElba R. Leyva-Huerta
Elba R. Leyva-Huerta
Mucoepidermoid carcinoma (MC) is the most common malignant epithelial neoplasm in the salivary glands. This neoplasm has varying proportions of mucous, epidermoid, intermediate, columnar, and clear cells. MCs have been associated with CRTC1-MAML2 genes; however, their pathogenesis is uncertain. Recently, epigenetic changes have been considered a possible aetiologic factor. To identify the methylation state of RB, P16, MGMT, and hMLH genes in the three severity grades of MC were used five MCs and one healthy minor salivary gland as a control group (CG) obtained from the Pathology and Oral Medicine Laboratory and analyzed using MS-PCR to compare the presence or absence of methylation in promotor regions. The Kruskal-Wallis test was performed, with p≤0.05 considered significant. CG was employed as the normalizer of methylation levels. All assays were performed in triplicate. The mean age of our population was 52.6±18.6 years old; the total population was female and included 2 low grade, 2 intermediate grade, and 1 high grade levels of severity. When comparing the methylation status of the three histopathological grades of MC against the control, statistically significant differences were observed in Rb-M, MGMT-M, and hMLH-1-NM for high-grade severity, with p values of 0.03, 0.05, and 0.04, respectively. Methylation is a possible mechanism for pathogenesis processing of high-grade MC. However, a larger sample population is necessary to validate this finding. El carcinoma mucoepidermoide (CM) es la neoplasia epitelial maligna más frecuente de glándulas salivales. Esta neoplasia tiene proporciones variables de células mucosas, epidermoides, intermedias, cilíndricas y claras. Los CM se han asociado con los genes CRTC1-MAML2; sin embargo, su patogenia es incierta. Recientemente, los cambios epigenéticos se han considerado un posible factor etiológico. Para identificar el estado de metilación de los genes RB, P16, MGMT y hMLH en los tres grados de severidad de CM se utilizaron cinco CM y una glándula salival menor sana como grupo control (GC) obtenidos del Laboratorio de Patología y Medicina Oral y analizados mediante MS-PCR para comparar la presencia o ausencia de metilación en regiones promotoras. Se realizó la prueba de Kruskal-Wallis, considerándose significativa una p≤0,05. Se empleó GC como normalizador de los niveles de metilación. Todos los ensayos se realizaron por triplicado. La edad media de nuestra población fue de 52,6 ± 18,6 años; la población total era femenina e incluía 2 niveles de severidad de grado bajo, 2 de grado intermedio y 1 de alto grado. Al comparar el estado de metilación de los tres grados histopatológicos de CM contra el GC, se observaron diferencias estadísticamente significativas en Rb-M, MGMT-M y hMLH-1-NM para severidad de alto grado, con valores de p de 0.03, 0.05, y 0,04, respectivamente. La metilación es un posible mecanismo para el procesamiento de patogénesis de CM de alto grado. Sin embargo, se necesita una población de muestra más grande para validar este hallazgo.

18 March 2025 in Reports
Verified
Journal Article
Open access
PDF file
GGGABRIELA GONZÁLEZ
GABRIELA GONZÁLEZ
SMSamuel Mendoza-Álvarez
Samuel Mendoza-Álvarez
CMClaudia Patricia Mejia-Velazquez
Claudia Patricia Mejia-Velazquez
CRCarla Monserrat Ramírez-Martínez
Carla Monserrat Ramírez-Martínez
AAAlejandro Alonso-Moctezuma
Alejandro Alonso-Moctezuma
LJLuis Fernando Jacinto-Alemán
Luis Fernando Jacinto-Alemán
Background and Clinical Significance: Basal cell nevoid carcinoma syndrome, or Gorlin–Goltz Syndrome (GGS), is a genetic disease caused by germline mutations in genes involved in the Sonic HedgeHog (SHH) signaling pathway, mainly in the PTCH1 gene. PTCH1 is a receptor for SHH, and the activation of SHH signaling exerts a direct effect on the proliferation and maintenance of stem cells; alteration of its signaling could promote a favorable microenvironment for the maintenance of tumor viability. The main clinical manifestations of patients with GGS include multiple basal cell carcinomas, odontogenic keratocysts, calcification of the falx cerebri, palmoplantar fossae, hypertelorism, prognathism, fused or bifid ribs, and macrocephaly, which occur at different stages of life. Case Presentation: Here, the case of a 48-year-old woman is described, for whom a clinical and histopathological diagnosis of GGS was made due to the presence of two major criteria (multiple odontogenic keratocysts and calcification of the falx cerebri) and one minor criterion (congenital anomalies), according to Kimonis. Additionally, an end-point RT-PCR assay showed a decrease in PTCH1 gene expression. A conservative therapy was established, and satisfactory results were obtained in a follow-up period of 18 months. Conclusions: Kimonis' clinical criteria are important for establishing the diagnosis of Gorlin syndrome.